Your browser doesn't support javascript.
loading
[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia].
Shlyakhto, E V; Sukhikh, G T; Serov, V N; Dedov, I I; Arutyunov, G P; Suchkov, I A; Orlova, Ya A; Andreeva, E N; Yureneva, S V; Yavelov, I S; Yarmolinskaya, M I; Villevalde, S V; Grigoryan, O R; Dudinskaya, E N; Ilyukhin, E A; Koziolova, N A; Sergienko, I V; Smetnik, A A; Tapilskaya, N I.
Afiliación
  • Shlyakhto EV; National Medical Research Center named after V.A. Almazov.
  • Sukhikh GT; National Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
  • Serov VN; National Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
  • Dedov II; Endocrinology Research Center.
  • Arutyunov GP; Russian National Research Medical University named after N.I. Pirogov.
  • Suchkov IA; Ryazan State Medical University I.P. Pavlova.
  • Orlova YA; Medical Research and Educational Center of Moscow State University named after M.V. Lomonosov.
  • Andreeva EN; Endocrinology Research Center.
  • Yureneva SV; National Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
  • Yavelov IS; National Medical Research Center for Therapy and Preventive Medicine.
  • Yarmolinskaya MI; Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Otta.
  • Villevalde SV; National Medical Research Center named after V.A. Almazov.
  • Grigoryan OR; Endocrinology Research Center.
  • Dudinskaya EN; Russian Gerontological Research and Clinical Center of the Russian National Research Medical University named after N.I. Pirogov.
  • Ilyukhin EA; Medalp LLC.
  • Koziolova NA; Perm State Medical University named after. acad. E.A. Wagner.
  • Sergienko IV; National Medical Research Center of Cardiology E.I. Chazov.
  • Smetnik AA; National Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
  • Tapilskaya NI; Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Otta.
Probl Endokrinol (Mosk) ; 69(5): 115-136, 2023 Nov 12.
Article en Ru | MEDLINE | ID: mdl-37968959
Menopausal symptoms can disrupt the life course of women at the peak of their career and family life. Currently, the most effective treatment for these manifestations is menopausal hormone therapy (MHT). The presence of cardiovascular and metabolic diseases in itself does not exclude the possibility of prescribing MHT to relieve menopausal symptoms and improve quality of life. However, often an obstacle to the use of this type of hormonal therapy is the fear of doctors who are afraid of doing more harm to patients than good. Caution is especially important when it comes to women with underlying health conditions. Moreover, it should be recognized that there is a lack of high-quality research regarding the safety of MHT for major chronic non-infectious diseases and common comorbid conditions. The presented consensus document analyzed all currently available data obtained from clinical trials of various designs and created a set of criteria for the acceptability of prescribing MHT to women with concomitant cardiovascular and metabolic diseases. Based on the presented document, doctors of various specialties who advise women in menopause will receive an accessible algorithm that will allow them to avoid potentially dangerous situations and reasonably prescribe MHT in real practice.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Reemplazo de Estrógeno / Enfermedades Metabólicas Límite: Female / Humans Idioma: Ru Revista: Probl Endokrinol (Mosk) Año: 2023 Tipo del documento: Article Pais de publicación: Rusia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Reemplazo de Estrógeno / Enfermedades Metabólicas Límite: Female / Humans Idioma: Ru Revista: Probl Endokrinol (Mosk) Año: 2023 Tipo del documento: Article Pais de publicación: Rusia